Month: May 2021

VANCOUVER, British Columbia, May 20, 2021 (GLOBE NEWSWIRE) — Endeavour Silver Corp. (TSX: EDR, NYSE: EXK) has intersected high grade gold-silver mineralization in its 2021 exploration drill program to expand the Melladito and Belen orebodies at the Bolañitos Mine in Guanajuato State, Mexico.   The Company is currently producing from four orebodies at Bolañitos: Plateros, Lucero, San Miguel and Melladito. Exploration drilling is ongoing along the Melladito and Belen veins (view longitudinal sections here). Highlights from the latest drill results include:8.09 grams per tonne (gpt) gold and 1,044 gpt silver for 1,611 gpt silver equivalent (AgEq at an 70:1 silver:gold ratio) over a 1.0 metre (m) true width (47.0 oz per short ton (opT) AgEq over 3.3 feet (ft)), including 14.2 gpt gold and 1,974 gpt silver for 2,966 gpt AgEq over...

Brings Ketamine treatments for anxiety, depression and PTSD to the home; Supports Ketamine clinics and mental health professionals. MIAMI, May 20, 2021 (GLOBE NEWSWIRE) — Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today its KetaDASH subsidiary has commenced data collection for potential patients and partnering clinics. KetaDASH, which is a HIPAA compliant, cloud based platform, will be first to market as a home healthcare provider offering IV based infusion therapy of ketamine. KetaDASH is available to ketamine clinics and qualified patients whose healthcare provider has prescribed it as a treatment. Qualified patients, doctors, and clinics are invited to visit https://www.ketadash.com/sign-up/ for more information. KetaDASH has designed...

First Quarter Total Net Revenue Decreases 18% to RUB 5,161 Million and Adjusted Net Profit Increases 18% to RUB 2,061 Million or RUB 33.00 per diluted shareQIWI reiterates 2021 GuidanceBoard of Directors Approves Dividends of 22 cents per share NICOSIA, Cyprus, May 20, 2021 (GLOBE NEWSWIRE) — QIWI plc (NASDAQ: QIWI) (MOEX: QIWI) (“QIWI” or the “Company”) today announced its financial results for the first quarter ended March 31, 2021. First Quarter 2021 Operating and Financial HighlightsTotal Net Revenue decreased 18% to RUB 5,161 million ($68.2 million) Payment Services Segment Net Revenue decreased 11% to RUB 4,762 million ($62.9 million) Adjusted EBITDA increased 23% to RUB 2,820 million ($37.3 million) Adjusted Net Profit increased 18% to RUB 2,061 million ($27.2 million), or RUB 33.00 per diluted share Payment Services Segment...

IPO bolsters balance sheet to $160 million in cash and cash equivalents; expected to fund operations at least into the second half of 2023 Clinical development plans on schedule in both hematological and solid tumor programs Leadership strengthened through key management and board appointments UTRECHT, The Netherlands and PHILADELPHIA, May 20, 2021 (GLOBE NEWSWIRE) — LAVA Therapeutics N.V. (Nasdaq: LVTX), a biotechnology company focused on applying its expertise in gamma-delta bispecific T cell engagers (bsTCEs) to transform cancer therapy, today reported its business update and first quarter 2021 financial results. “We continue to make important strides across all aspects of our business as we transition to a clinical stage organization,” said Stephen Hurly, chief executive officer of LAVA Therapeutics. “With the recent additions...

SHENZHEN, China, May 20, 2021 (GLOBE NEWSWIRE) — Xunlei Limited (“Xunlei” or the “Company”) (Nasdaq: XNET), a leading innovator in shared cloud computing and blockchain technology in China, today announced its unaudited financial results for the first quarter ended March 31, 2021. First Quarter 2021 Financial Highlights:Total revenues were US$53.3 million, representing an increase of 5.9% from the previous quarter.Cloud computing and other internet value-added services (“Cloud computing and other IVAS”) revenues were US$27.3 million, representing an increase of 5.7% from the previous quarter.Subscription revenues were US$22.1 million, representing an increase of 6.9% from the previous quarter.Online advertising revenues (consisting primarily of revenues from mobile advertising) were US$3.9 million, representing an increase...

NOT FOR DISTRIBUTION, RELEASE OR REPUBLICATION, DIRECTLY OR INDIRECTLY, TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION, RELEASE OR REPUBLICATION WOULD BE UNLAWFUL. Reference is made to the stock exchange announcement made by BW Ideol AS (the “Company”) on 5 May 2021, regarding the resolution to increase the share capital of the Company with NOK 41,732.70 through issuance of 417,327 new shares in order to satisfy the Company’s obligation to deliver shares following exercise of the greenshoe option. The share capital increase related to the issuance of these shares has now been registered with the Norwegian Register of Business Enterprises (Nw. Foretaksregisteret). Following such registration, the new share capital...

Recent Financial and Operating HighlightsStrong financial performance continued. In the first quarter, top and bottom line remained strong, as revenue increased by 63.9% year-over-year to RMB643.4 million (US$98.2 million) and net income turned positive for the first time and reached RMB58.2 million (US$8.9 million). Adjusted net income and adjusted EBITDA reached historical high and increased by 175.8% and 70.4% year-over-year to RMB109.3 million (US$16.7 million) and RMB307.8 million (US$47.0 million) respectively. Our adjusted EBITDA to interest ratio was 5.3 for the quarter. Released second annual ESG report, green effort continued to be recognized. On April 3, 2021, the Company released its second annual ESG report. Meanwhile, the Company’s green effort continued to be highly recognized in the industry. In the annual clean energy...

THIS NOTICE IS IMPORTANT AND REQUIRES THE IMMEDIATE ATTENTION OF NOTEHOLDERS. IF ANY NOTEHOLDER IS IN ANY DOUBT AS TO THE ACTION IT SHOULD TAKE, IT SHOULD SEEK ITS OWN FINANCIAL AND LEGAL ADVICE, INCLUDING AS TO ANY TAX CONSEQUENCES, IMMEDIATELY FROM ITS BROKER, BANK MANAGER, SOLICITOR, ACCOUNTANT OR OTHER INDEPENDENT FINANCIAL, TAX OR LEGAL ADVISER. G4S International Finance plc (incorporated with limited liability in England and Wales) (the Issuer) NOTICE OF SEPARATE MEETINGS of the holders of the following outstanding series of its notes  ISIN/ Common Code Nominal Amount Outstanding€500,000,000 1.50 per cent. Notes due 2023 of the Issuer guaranteed by G4S plc XS1515216650 / 151521665 €500,000,000€500,000,000 1.50 per cent. Notes due 2024 of the Issuer guaranteed by G4S plc XS1619992883 / 161999288 €500,000,000€550,000,000...

BEIJING, May 20, 2021 (GLOBE NEWSWIRE) — Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced a strategic partnership with JD Health, a subsidiary of JD.com, Inc., and the largest online healthcare platform in China. The two companies aim to create innovative solutions for full-cycle cancer management. The partnership encompasses both online and offline components, and focuses on six key areas: consumer healthcare, digitization of liver disease management, government medical associations, sharing of customer screening resources, industry and user education, and consolidation of oncology doctors and experts on...